help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This version published online on February 5, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2449
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/4/1123    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lodish, M. B.
Right arrow Articles by Gorden, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lodish, M. B.
Right arrow Articles by Gorden, P.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Endocrine Oncology

Submitted on November 5, 2007
Accepted on January 28, 2008

Insulinoma and Gastrinoma Syndromes from a Single Intrapancreatic Neuroendocrine Tumor

Maya B. Lodish MD, Anathea C. Powell MD, Mones Abu-Asab MD, Craig Cochran CRNP, Petra Lenz MD, Steven K. Libutti MD, James F. Pingpank MD, Maria Tsokos MD, and Phillip Gorden MD*

National Institute of Child Health and Human Development; Surgery Branch, National Cancer Institute; Laboratory of Pathology, National Cancer Institute; Clinical Endocrinology Branch, Division of Intramural Research, National Institute of Diabetes and Digestive and Kidney Diseases

* To whom correspondence should be addressed. E-mail: PhillipG{at}intra.niddk.nih.gov.

Context: The insulinoma syndrome is marked by fasting hypoglycemia and inappropriate elevations of insulin. The gastrinoma syndrome is characterized by hypergastrinemia, ulcer disease and/or diarrhea. Rarely, insulinoma and gastrinoma coexist in the same patient simultaneously.

Objective: To determine the cause of a patient's hypoglycemic episodes and peptic ulcer disease.

Design: Clinical case report.

Setting: Clinical Research Center of the National Institutes of Health.

Patients: One patient with hypoglycemic episodes and peptic ulcer disease.

Intervention: Surgical resection of neuroendocrine tumor.

Results: The patient was found to have a single tumor co-secreting both insulin and gastrin. Resection of this single tumor was curative.

Conclusions: A single pancreatic neuroendocrine tumor may lead to the expression of both the hyperinsulinemic and hypergastrinemic syndromes.
Key words: Insulinoma • gastrinoma • MEN1






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society